Jay Olson
Stock Analyst at Oppenheimer
(4.88)
# 319
Out of 5,053 analysts
1181
Total ratings
49%
Success rate
25%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGMT Sagimet Biosciences | Reiterated: Buy | $33 → $38 | $7.98 | +376.19% | 9 | Oct 1, 2026 | |
| VKTX Viking Therapeutics | Rated: Buy | $100 → $120 | $26.65 | +350.28% | 40 | Sep 22, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $60 → $75 | $34.38 | +118.15% | 8 | Sep 14, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | $32 | $11.76 | +172.22% | 2 | Aug 27, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 → $260 | $188.44 | +37.97% | 26 | Aug 27, 2026 | |
| BIIB Biogen | Rated: Hold | n/a | $228.90 | - | 100 | Aug 17, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $650 | $243.34 | +167.12% | 7 | Aug 17, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $35 | $5.87 | +496.25% | 2 | Aug 14, 2026 | |
| APRE Aprea Therapeutics | Reiterated: Buy | $5 | $0.60 | +733.33% | 2 | Aug 13, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $24.16 | $9.59 | +151.91% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $5.57 | +797.67% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.07 | +834.58% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $8.06 | +396.28% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $412.84 | +9.00% | 84 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $21.51 | +178.94% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $135.13 | +70.21% | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $120 | $108.62 | +10.48% | 84 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9982 | - | 2 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.53 | - | 15 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $485.22 | - | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.14 | +79.53% | 4 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $2.40 | +275.00% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $18.40 | +117.39% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.04 | +861.54% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $140 | $37.92 | +269.20% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $89.01 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $59.51 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.64 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 → $72 | $37.03 | +94.44% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $216.25 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $36 | $3.63 | +891.74% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.56 | +742.70% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $452.12 | +43.77% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7818 | +667.46% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.19 | +219.63% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $27 | $11.91 | +126.70% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $42.38 | +112.36% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.41 | n/a | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $2.15 | n/a | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.4956 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.36 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.01 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $147.92 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $11.52 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $18.62 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $50.10 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.45 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8017 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $10 | $18.56 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.20 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.81 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $3.36 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.83 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6813 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $1.96 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $7 | $12.22 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.39 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.16 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2148 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.62 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.03 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.13 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $0.25 | $3.05 | n/a | 5 | Mar 30, 2016 |
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $33 → $38
Current: $7.98
Upside: +376.19%
Viking Therapeutics
Sep 22, 2026
Rated: Buy
Price Target: $100 → $120
Current: $26.65
Upside: +350.28%
Definium Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $75
Current: $34.38
Upside: +118.15%
Adlai Nortye Group
Aug 27, 2026
Reiterated: Buy
Price Target: $32
Current: $11.76
Upside: +172.22%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $260
Current: $188.44
Upside: +37.97%
Biogen
Aug 17, 2026
Rated: Hold
Price Target: n/a
Current: $228.90
Upside: -
Praxis Precision Medicines
Aug 17, 2026
Reiterated: Buy
Price Target: $650
Current: $243.34
Upside: +167.12%
Kyntra Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $5.87
Upside: +496.25%
Aprea Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $0.60
Upside: +733.33%
Eupraxia Pharmaceuticals Inc.
Aug 12, 2026
Reiterated: Buy
Price Target: $24.16
Current: $9.59
Upside: +151.91%
Aug 6, 2026
Reiterated: Buy
Price Target: $50
Current: $5.57
Upside: +797.67%
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $1.07
Upside: +834.58%
Aug 6, 2026
Reiterated: Buy
Price Target: $40
Current: $8.06
Upside: +396.28%
Aug 5, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $412.84
Upside: +9.00%
Aug 5, 2026
Reiterated: Buy
Price Target: $60
Current: $21.51
Upside: +178.94%
Jul 31, 2026
Reiterated: Buy
Price Target: $230
Current: $135.13
Upside: +70.21%
Jul 28, 2026
Reiterated: Buy
Price Target: $107 → $120
Current: $108.62
Upside: +10.48%
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $0.9982
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $485.22
Upside: -
Jul 7, 2026
Reiterated: Buy
Price Target: $20
Current: $11.14
Upside: +79.53%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.40
Upside: +275.00%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $18.40
Upside: +117.39%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $1.04
Upside: +861.54%
May 8, 2026
Reiterated: Buy
Price Target: $115 → $140
Current: $37.92
Upside: +269.20%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $89.01
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $59.51
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $3.64
Upside: -
Apr 22, 2026
Reiterated: Buy
Price Target: $61 → $72
Current: $37.03
Upside: +94.44%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $216.25
Upside: -
Mar 18, 2026
Reiterated: Buy
Price Target: $44 → $36
Current: $3.63
Upside: +891.74%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $3.56
Upside: +742.70%
Feb 9, 2026
Reiterated: Buy
Price Target: $650
Current: $452.12
Upside: +43.77%
Nov 13, 2025
Reiterated: Buy
Price Target: $6
Current: $0.7818
Upside: +667.46%
Nov 13, 2025
Reiterated: Buy
Price Target: $7
Current: $2.19
Upside: +219.63%
Nov 7, 2025
Reiterated: Buy
Price Target: $40 → $27
Current: $11.91
Upside: +126.70%
Oct 27, 2025
Reiterated: Buy
Price Target: $90
Current: $42.38
Upside: +112.36%
Oct 7, 2025
Reiterated: Buy
Price Target: $8
Current: $1.41
Upside: n/a
Oct 2, 2025
Reiterated: Buy
Price Target: $18
Current: $2.15
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $65
Current: $0.4956
Upside: n/a
Jun 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.36
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $11.01
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $147.92
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: $14
Current: $11.52
Upside: n/a
Nov 8, 2024
Reiterated: Hold
Price Target: $17
Current: $18.62
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $95
Current: $50.10
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.45
Upside: n/a
Nov 4, 2024
Reiterated: Buy
Price Target: $9
Current: $0.8017
Upside: n/a
Oct 17, 2024
Reiterated: Buy
Price Target: $9 → $10
Current: $18.56
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $8.81
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $3.36
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $9.83
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $0.6813
Upside: n/a
Aug 22, 2019
Reiterated: Buy
Price Target: $10 → $9
Current: $1.96
Upside: n/a
Aug 14, 2019
Reiterated: Buy
Price Target: $15 → $7
Current: $12.22
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.39
Upside: n/a
Mar 24, 2019
Reiterated: Buy
Price Target: n/a
Current: $1.16
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.2148
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $2.62
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $12.03
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $6.13
Upside: n/a
Mar 30, 2016
Reiterated: Sell
Price Target: $2 → $0.25
Current: $3.05
Upside: n/a